Insulin aspart

  • Biologic
  • NOVOLOG

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Insulin aspart: storage and handling

Refrigerate
Yes, as the label states
Label statement
Store unused NOVOLOG in a refrigerator between 2°C to 8°C (36°F to 46°F).
Freezing
Do not freeze
Label statement
Do not freeze NOVOLOG and do not use NOVOLOG if it has been frozen.
Room temperature
up to 28 days at or below 30°C (86°F)
Label statement
Storage of Diluted NOVOLOG NOVOLOG diluted with Insulin Diluting Medium for NOVOLOG to a concentration equivalent to U-10 or equivalent to U-50 prepared as indicated under Dosage and Administration (2.2) may remain in patient use at temperatures up to 30°C (86°F) for 28 days.
Room temperature
up to 1 day
Label statement
Storage of NOVOLOG in Intravenous Infusion Fluids Infusion bags prepared as indicated under Dosage and Administration (2.2) are stable at room temperature for 24 hours.
Room temperature
up to 28 days at or below 8°C (46°F)
Label statement
All unopened vials: o Store unopened NovoLog vials in the refrigerator at 36 ° F to 46 ° F (2 ° C to 8 ° C). o Unopened vials may be used until the expiration date printed on the label, if they have been stored in the refrigerator. o Unopened vials should be thrown away after 28 days, if they are stored at room temperature. .
Room temperature
up to 28 days at or below 30°C (86°F)
Label statement
After vials have been opened: o Opened NovoLog vials can be stored in the refrigerator at 36 ° F to 46 ° F (2 ° C to 8 ° C) or at room temperature below 86 ° F (30 ° C). o Throw away all opened NovoLog vials after 28 days, even if they still have insulin left in them. o If using NovoLog in a pump, throw away all opened NovoLog vials after 19 days.
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 28 days at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Storage of Diluted NOVOLOG NOVOLOG diluted with Insulin Diluting Medium for NOVOLOG to a concentration equivalent to U-10 or equivalent to U-50 prepared as indicated under Dosage and Administration (2.2) may remain in patient use at temperatures up to 30°C (86°F) for 28 days.
Always remove and discard the needle after each injection from the NOVOLOG FlexPen or NOVOLOG FlexTouch and store without a needle attached.
After vials have been opened: o Opened NovoLog vials can be stored in the refrigerator at 36 ° F to 46 ° F (2 ° C to 8 ° C) or at room temperature below 86 ° F (30 ° C). o Throw away all opened NovoLog vials after 28 days, even if they still have insulin left in them. o If using NovoLog in a pump, throw away all opened NovoLog vials after 19 days.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-727-6500 (the number printed on the label) about this product.

Where the label prints this number
License Number 1261 For more information, go to www.novonordisk-us.com or call 1-800-727-6500.
All storage statements on the label (14)
  • Store unused NOVOLOG in a refrigerator between 2°C to 8°C (36°F to 46°F).
  • Do not freeze NOVOLOG and do not use NOVOLOG if it has been frozen.
  • Do not expose NOVOLOG to excessive heat or light.
  • Do not withdraw NOVOLOG into a syringe and store for later use.
  • Always remove and discard the needle after each injection from the NOVOLOG FlexPen or NOVOLOG FlexTouch and store without a needle attached.
  • Storage in External Insulin Pump: Change the NOVOLOG in the pump reservoir at least every 7 days or according to the pump user manual, whichever is shorter, or after exposure to temperatures that exceed 37°C (98.6°F).
  • Storage of Diluted NOVOLOG NOVOLOG diluted with Insulin Diluting Medium for NOVOLOG to a concentration equivalent to U-10 or equivalent to U-50 prepared as indicated under Dosage and Administration (2.2) may remain in patient use at temperatures up to 30°C (86°F) for 28 days.
  • Storage of NOVOLOG in Intravenous Infusion Fluids Infusion bags prepared as indicated under Dosage and Administration (2.2) are stable at room temperature for 24 hours.
  • How should I store NovoLog? .
  • Do not freeze NovoLog.
  • Do not use NovoLog if it has been frozen. .
  • Keep NovoLog away from heat or light. .
  • All unopened vials: o Store unopened NovoLog vials in the refrigerator at 36 ° F to 46 ° F (2 ° C to 8 ° C). o Unopened vials may be used until the expiration date printed on the label, if they have been stored in the refrigerator. o Unopened vials should be thrown away after 28 days, if they are stored at room temperature. .
  • After vials have been opened: o Opened NovoLog vials can be stored in the refrigerator at 36 ° F to 46 ° F (2 ° C to 8 ° C) or at room temperature below 86 ° F (30 ° C). o Throw away all opened NovoLog vials after 28 days, even if they still have insulin left in them. o If using NovoLog in a pump, throw away all opened NovoLog vials after 19 days.

FDA label version 34, effective February 28, 2023. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Biosimilars

Novolog: 3 licensed biosimilar products, 2 interchangeable (FDA Purple Book). Compare presentations and dates

Medicare Part D coverage

100%of plans list it
26%of those: prior authorization
0%step therapy
11%quantity limit
0%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.